Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi
- 1 June 1995
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 63 (6) , 2255-61
- https://doi.org/10.1128/iai.63.6.2255-2261.1995
Abstract
Outer surface protein A (OspA), which is abundantly expressed in cultured Borrelia burgdorferi, appears to be down-regulated or masked following low-dose infection, and OspA immunization did not prevent infection, dissemination, or disease development with host-adapted spirochetes. Seroconversion of mice to B. burgdorferi OspA depended on dose and viability of inoculated spirochetes. Mice inoculated with > 10(4) live spirochetes and > 10(7) heat-killed spirochetes seroconverted to OspA, but mice inoculated with fewer spirochetes did not seroconvert to OspA at 2 weeks after inoculation. Growth temperature of spirochetes was not a factor for infectious dose or seroconversion to OspA. Spirochetes grown at 30, 34, or 38 degrees C had the same median infectious dose. Growth temperature did not influence infectious dose when mice were inoculated intraperitoneally or intradermally and did not influence dose-related immunologic recognition of OspA. Mice hyperimmunized with recombinant OspA-glutathione S-transferase (GT) fusion protein or GT (controls) were challenged by syringe inoculation with 10(3) spirochetes or by transplantation of infected skin from syngenic mice infected for 2 or 8 weeks. OspA-GT-immunized mice resisted syringe challenge but developed disseminated infections following transplantation of infected skin. Identical results were obtained in mice passively immunized with hyperimmune serum to OspA-GT or GT and then challenged by syringe or infected skin transplant. The number of spirochetes in infected skin, determined by quantitative PCR directed toward both plasmid and genomic targets, was less than the syringe challenge dose.Keywords
This publication has 42 references indexed in Scilit:
- Early and specific antibody response to OspA in Lyme Disease.Journal of Clinical Investigation, 1994
- Nucleotide sequence and analysis of the gene inBorrelia burgdorferiencoding the immunogenic P39 antigenFEMS Microbiology Letters, 1994
- Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bitesImmunology Letters, 1994
- Target Imbalance: Disparity of Borrelia burgdorferi Genetic Material in Synovial Fluid from Lyme Arthritis PatientsThe Journal of Infectious Diseases, 1994
- Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines.The Journal of Experimental Medicine, 1993
- Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigenImmunology Letters, 1993
- Western blot analysis of sera from Lyme borreliosis patients according to the genomic species of theBorrelia strains used as antigensEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotypeVaccine, 1993
- The major histocompatibility complex-restricted response of recombinant inbred strains of mice to natural tick transmission of Borrelia burgdorferi.The Journal of Experimental Medicine, 1993
- Nonspecific Proliferative Responses of Murine Lymphocytes to Borrelia burgdorferi AntigensThe Journal of Infectious Diseases, 1992